Ursula Rescher

University of Münster

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (14)

Carsten Theiss

Ruhr-Universität Bochum

GERMANY

View details

Giuliano Ciarimboli

University Hospital Münster

GERMANY

View details

Shuyu Zheng

University of Helsinki

FINLAND

View details

Anne Balkema-Buschmann

Deputy head, Senior Scientist

Friedrich-Loeffler-Institut

GERMANY

View details

Susann Kummer

Head of Project Group - AG4 Stability and Persistence of Risk Group 4 Viruses

Robert Koch Institute

GERMANY

View details

Cornelius Faber

GERMANY

View details

Carles Rentero

Associate Professor

University of Barcelona

SPAIN

View details

Stephan Ludwig

Full Professor and Director

Westfälische Wilhelms Universität Münster Medizinische Fakultät

GERMANY

View details

Karin Klingel

Head of Cardiopathology/Infection Pathology

University Hospital

GERMANY

View details

Wolfgang A. Linke

GERMANY

View details

Michael Geisow

UNITED KINGDOM

View details

Jesper Nylandsted

Professor

University of Southern Denmark

DENMARK

View details

Thomas Grewal

Associate Professor

University of Sydney

AUSTRALIA

View details

Jyoti Jaiswal

Professor

The George Washington University School of Medicine and Health SCiences

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ursula Rescher

Research Interests

Explore related searches

Contact this professor

Articles (12)

Annexins—a family of proteins with distinctive tastes for cell signaling and membrane dynamics

Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells

Pathophysiological Mechanisms of Cardiac Dysfunction in Transgenic Mice with Viral Myocarditis

The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs

3D <i>ex vivo</i> tissue platforms to investigate the early phases of influenza A virus- and SARS-CoV-2-induced respiratory diseases.

Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection in vitro

Repurposing Antifungals for Host-Directed Antiviral Therapy?

Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro

Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro.

Annexin Animal Models—From Fundamental Principles to Translational Research

Can you teach an old receptor new tricks?

ANO5 in membrane repair - Status: “It’s complicated”

Collaborators (14)

Carsten Theiss

Giuliano Ciarimboli

Shuyu Zheng

Anne Balkema-Buschmann

Susann Kummer

Cornelius Faber

Carles Rentero

Stephan Ludwig

Karin Klingel

Wolfgang A. Linke

Michael Geisow

Jesper Nylandsted

Thomas Grewal

Jyoti Jaiswal

Make your next move.